STATIN TREATMENT AND RISK OF CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH MYOCARDIAL INFARCTION IN AN INTEGRATED HEALTHCARE SYSTEM

Authors :: Catherine B McGuiness
Pallavi Rane
Abdelhadi Rifai
Belinda Schludi
Rasha Alkhatib
Yi Li
Yangyang Liu
Mohdhar Habib
Rolin L Wade
Neal Sawlani
Source :: Journal of the American College of Cardiology. 75:264
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.
Abstract: Physician prescription patterns for lipid lowering therapy, particularly high-intensity statins (HIS), and risk of cardiovascular events (CVE) is not well documented in the real-world clinical setting among patients hospitalized with acute myocardial infarction (AMI). We aim to examine the

Subjects :: medicine.medical_specialty
business.industry
Statin treatment
medicine.disease
Lipid-lowering therapy
Emergency medicine
medicine
cardiovascular diseases
Myocardial infarction
Medical prescription
Cardiology and Cardiovascular Medicine
business
Cardiovascular outcomes
Healthcare system

Full Text Access

Tools